Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

gallium Ga 68-labeled alphaVbeta6 binding peptide RAD 301

A radiotracer composed of RAD301, which comprises an integrin alphaVbeta6 (aVb6) binding peptide (BP) and is radiolabeled with the radionuclide gallium Ga 68, with potential integrin aVb6 imaging activity using positron emission tomography (PET). Upon administration of gallium Ga 68-labeled alphaVbeta6 binding peptide RAD301, the aVb6-binding peptide moiety selectively targets and binds to integrin aVb6-positive cancer cells. During PET, aVb6-expressing tumor cells can be visualized and the degree of tumor growth can be determined. Integrin aVb6, a cell adhesion and signaling receptor, is upregulated in certain cancer cell types and has been associated with increased proliferation, migration and invasion of tumor cells.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:68Ga-trivehexin
gallium Ga 68 trivehexin
radiotracer RAD 301
Code name:RAD 301
RAD-301
RAD301
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search